Vioxx scandal

The Vioxx scandal revolves around the painkiller Vioxx (rofecoxib), developed by Merck & Co. and released in 1999. It was designed to treat arthritis and pain but was withdrawn in 2004 after studies revealed it significantly increased the risk of heart attacks and strokes. Critics accused Merck of downplaying these risks and not fully disclosing data in their studies. This led to lawsuits, scrutiny of drug approval processes, and highlighted the importance of transparency in pharmaceutical companies. The scandal raised public awareness about the potential dangers of medications and the need for rigorous safety assessments.